MSB

3.21%

$1.13 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-325

First 325 Last

Share
Profile

Follow
Wilba32

6,922 Posts.

1521

25/02/24

16:36

Post #: 72584520
Share

Originally posted by Southoz: ↑

Bedger thanks for the compliments and sorry to disappoint but I don’t think (and am nearly certain) I am really going to add much new to the mix here.

Like a lot of people these days I don’t pay much attention to what MSB has to say about their interactions and progress with the FDA; unless there is some sort of independent corroboration.

Presumably at some point MSB they will try for third time lucky. The current share price of 30c suggests that the market doesn’t anticipate anything very positive in the near term. The punt it seems is very much one for the dwindling number of true believers.

So without anything very sensible to say - for a bit of light relief - I did find something pretty funny a few nights ago.

About once a year my wife provides me with my own personal Complete Complaint Session (CCS). In the past I have found these to be rather deflating experiences but this time around I decided to use the Dr Krause method.

Dr Krause explains the method as follows.

“Sure. I will make a quick point here and that is the CRL had, although, of course, the disappointment of being a CRL, but had two positive indicators in it as well or two significant positive indicators. One of course was the favorable results of the inspection, but the other important thing to take note of is that, the CRL did not question the efficiency of the product as was demonstrated in GVHD001, as had been the case in the previous CRL”

Applying the method at home.

“Sure it was a little disappointing to receive another CCS from my wife. But there were two positive indicators in it as well. First my wife was overjoyed that I am now putting my clothes in the laundry basket instead of dropping them on the floor. But the other important thing to take note of is that in the CCS she did not raise the issue of the leaky laundry toilet as had been the case in the previous CCS session.”

It might seem a small thing but the leaky toilet has been a thorn in the side of our otherwise perfect collegiate relationship for over five years. She did have a rather entrenched position; something to do with the pump going off all times of the night and day. But I’m just so happy she has finally accepted I was right all along - it is impossible to fix leaky toilets and we need to just accept things we cant change.

So it worked for me. The Dr Krause method has been life changing. All shareholders should try it following their next CCS with their loved ones.

The moral of the tale of the little skit. Companies develop their clinical program through FDA dot joining are going to as successful as people who think that just because their partner stops complaining about something that this proves they are now happy about it.

Expand

Funny you should mention the toilet…

Broken toilet, fence palings missing, broken light, doors off hinges, lounge chairs missing vegan leather, carpet & Lino vanishing into thin air & car just going, are all on my Silviu to-do jobs List. Just got to get the #1 job done first - fda approval!

MSB Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 38 more messages in this thread...

First 325 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.13		Change 0.035(3.21%)		Mkt cap ! $1.284B

Open	High	Low	Value	Volume
$1.09	$1.13	$1.07	$3.910M	3.535M

Buyers (Bids)

No.	Vol.	Price($)
2	27197	$1.11

Sellers (Offers)

Price($)	Vol.	No.
$1.13	43578	3

View Market Depth

No.	Vol.	Price($)
4	31763	1.100
2	33264	1.090
2	18897	1.085
2	18926	1.080
1	18000	1.075

Price($)	Vol.	No.
1.130	23400	3
1.135	1090	1
1.140	65000	4
1.145	64500	3
1.150	92314	9

Last trade - 16.10pm 27/09/2024 (20 minute delay)

MSB (ASX) Chart

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-325

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-325

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News